Janet Wei works in Cardiac Imaging affiliated with Cedars-Sinai Smidt Heart Institute.
Janet Wei is a cardiologist and Associate Professor of Cardiology at Cedars-Sinai Medical Center. She serves as the Associate Medical Director of the Biomedical Imaging Research Institute and Co-Director of the Stress Echocardiography Lab at Cedars-Sinai. Her research focuses on ischemic heart disease in women, including the use of cardiac imaging to assess myocardial perfusion and coronary reactivity.
349 pubs · 6,176 cites · h-index 38
MD
Northwestern University The Feinberg School of Medicine
2007
Associate Professor of Cardiology
Cedars-Sinai Medical Center · 2015 - Present
Intensify guideline-directed care in women aged 35-54 to reverse rising IHD mortality; extends prior data with targeted strategies for CAD phenotypes.
Cardiologist, Emory University School of Medicine
This study provides evidence that impaired microvascular function involving endothelial-dependent or independent pathways, or even both, predicts the adverse cardiovascular outcomes in women with signs and symptoms of ischemia but no obstructive coronary artery disease.
Journal of the American College of CardiologyAlBadri et al.
Comprehensive, multidisciplinary management programs and collaborative research are critical for improving care and outcomes in patients with ANOCA.
LVEDP elevation in INOCA women links to BMI and SBP without CMD correlation; hypothesis-generating and should not yet change practice.
Multimodal brain MRI connectivity (USFC) serves as a sensitive biomarker linking cerebral network efficiency with coronary microvascular dysfunction in women with INOCA.
Critically ill COVID-19 patients may develop right ventricular thrombus and obstructive shock, highlighting the need to consider cardiogenic components in worsening shock.
Advances in diagnostic testing now allow for routine evaluation of ANOCA noninvasively and in the cardiac catheterization laboratory with coronary function testing.
Standardizes care for acquired CVD across peripartum period; reinforces multidisciplinary approaches to optimize maternal-fetal outcomes.
Randomised controlled trial examines intensive medical treatment effects on major events in women with suspected ANOCA/INOCA, suggesting further investigation is needed.
A novel, rapid cardiac MRI framework enables noninvasive quantification of myocardial oxygen consumption, offering a potential tool for early disease detection and personalized therapy in heart failure.
LL-37 antigen-specific immune profiling differentiates ASCVD phenotypes (MI, stroke, PAD), providing mechanistic insights into their distinct pathophysiologies.
Supports coronary function testing to guide therapy in INOCA; reinforces guidelines and extends prior endotype evidence.
May warrant long-term follow-up after Takotsubo syndrome; extends prior observations of adverse post-recovery outcomes.
This ancillary study will be the first to quantify the impact of intensive medical therapy versus usual care on coronary plaque composition and outcomes in women with suspected INOCA using CCTA.
Observational analysis reveals a dose-response relationship between uric acid to HDL ratio and microalbuminuria in individuals with type 2 diabetes, indicating potential for improved risk assessment.
This pilot study applies QSM to detect myocardial inflammation in pigs with myocardial infarction, suggesting its utility in monitoring heart healing.
Pilot study reveals cardiac MRI can assess myocardial efficiency in post-MI heart failure patients, suggesting further exploration is needed.
This analysis demonstrates reduced T2 variation across the cardiac cycle in hypertrophic cardiomyopathy, indicating potential myocardial abnormalities.
